Randomized controlled trial for anti-reflux effect of tubulogastric jejunal anastomosis in radical resection of advanced esophageal carcinoma

Anti-reflux effect of tubulogastric jejunal anastomosis in radical resection of advanced esophageal carcinoma

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061424

Enrollment

Unknown

Registered

2022-06-24

Start date

2022-07-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Experimental group:gastric tube reconstruction with Roux-en-Y anastomosis

Control group: no gastric tube reconstruction with Roux-en-Y anastomosis

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Histologically confirmed esophageal carcinoma; 3. Resectable cT1-T3/N0-N1 esophageal carcinoma; 4. ECOG score 0-1; 5. Cardiopulmonary function can tolerate surgery.

Exclusion criteria

Exclusion criteria: 1. History of other malignant tumors; 2. The patient was unable to complete the entire follow-up period due to other serious systemic diseases; 3. Patients with a history of gastric surgery; 4. Patients could not comply to complete the follow-up period.

Design outcomes

Primary

Measure	Time frame
anti-reflux effect;	—

Secondary

Measure	Time frame
nutritional status;	—

Countries

China

Contacts

Public ContactLi Mengbin

Xijing Hospital Affiliated to Air Force Medical University

limbin@live.cn+86 15902988001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026